Bespoke fully automated packaging solution helps secure success of Global Phase III Mega Trial
When drug manufacturers have established key findings from Phase I and Phase II studies, such as safe dosage, side effects and patient response to new therapeutic interventions, it’s time to move on to a Phase III trial.
Phase III studies can involve thousands of patients, across multiple clinical sites and across multiple global locations. With this brings several supply and demand-based challenges. One of these challenges relates to packaging and, more specifically, the design materials, operating forecasts and equipment needed to effectively and compliantly process and package clinical supplies.
To learn how one global pharmaceutical company overcame a number of packaging challenges arising from the scale and complexity of their Phase III clinical trial, download our case study by completing the form.View Resource
Almac Clinical Services
Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognised as an innovative, global solution provider within the specialised and complex market of clinical trial supply.
Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.
Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.